BANGALORE: Biotechnology firm Bharat Biotech International has launched BioHib, the first indigenously developed and manufactured Haemophilus Influenza Type B (Hib) vaccine in India, and Comvac 4-HB, a tetravalent combination vaccine. “BioHib is a safe and affordable vaccine that offers complete protection against Hib Infection”, a company release said. “BioHib is a conjugate vaccine that has proven its safety and efficacy in multi-centric clinical trials”.